Quartiles of peak troponin are associated with long-term risk of death in type 1 and STEMI, but not in type 2 or NSTEMI patients
- PMID: 19911352
- PMCID: PMC6652998
- DOI: 10.1002/clc.20662
Quartiles of peak troponin are associated with long-term risk of death in type 1 and STEMI, but not in type 2 or NSTEMI patients
Abstract
Background: The prognostic value of peak cardiac troponin (cTn) in different types of acute myocardial infarction (AMI) under the universal clinical classification is unknown.
Hypothesis: We tested the hypothesis that the prognostic value of cTn varies with its peak level and type of AMI.
Methods: We studied 345 consecutive patients with AMI with mean follow-up of 30.6 months according to quartiles of peak cTn level (QPTL) and the type of AMI. The study outcomes were the major adverse cardiovascular events (MACE; composite of all causes of mortality and recurrent AMI) and the individual components of MACE.
Results: The study included patients with AMI Type 1 (n = 276), type 2 (n = 54), ST-segment elevation myocardial infarction (STEMI; n = 159), and non-ST-segment elevation myocardial infarction (NSTEMI; n = 186). Overall, peak cTn level was an independent predictor of MACE (hazard ratio [HR]: 1.001, 95% confidence interval [CI]: 1.000-1.003, P = 0.01) and death (HR: 1.002, 95% CI: 1.001-1.004, P = 0.003), but not of recurrent AMI. The highest risk of MACE and death was in the highest QPTL (61.6%, P = .016 and 66.3%, P = 0.021, respectively) while the highest risk of recurrent AMI was in the lowest QPTL (83.7%, P = 0.04). Quartiles of peak cTn level were significantly associated with increased risk of MACE and death in patients with Type 1 (all P = 0.01) and STEMI (P = 0.01 and P = 0.02, respectively), but no association existed in type 2 or NSTEMI patients.
Conclusions: Overall, peak cTn predicts the risk of MACE and death but not the risk of AMI. While in Type 1 and STEMI patients, QPTL are associated with risk of MACE and death, no association exists in type 2 or NSTEMI patients.
Similar articles
-
Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines.Clin Cardiol. 2012;35(7):424-9. doi: 10.1002/clc.21980. Epub 2012 Mar 20. Clin Cardiol. 2012. PMID: 22434769 Free PMC article.
-
Vitamin D and prognosis in acute myocardial infarction.Int J Cardiol. 2013 Oct 3;168(3):2341-6. doi: 10.1016/j.ijcard.2013.01.030. Epub 2013 Feb 13. Int J Cardiol. 2013. PMID: 23415169
-
Clinical Presentation, Management and Outcome of Japanese Patients With Acute Myocardial Infarction in the Troponin Era - Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) -.Circ J. 2015;79(6):1255-62. doi: 10.1253/circj.CJ-15-0217. Epub 2015 Apr 24. Circ J. 2015. PMID: 25912696
-
Contemporary NSTEMI management: the role of the hospitalist.Hosp Pract (1995). 2020 Feb;48(1):1-11. doi: 10.1080/21548331.2020.1701329. Epub 2020 Feb 20. Hosp Pract (1995). 2020. PMID: 31815570 Review.
-
High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.Crit Rev Clin Lab Sci. 2017 May;54(3):143-172. doi: 10.1080/10408363.2017.1285268. Epub 2017 May 1. Crit Rev Clin Lab Sci. 2017. PMID: 28457177 Review.
Cited by
-
New Electrocardiographic Algorithm for the Diagnosis of Acute Myocardial Infarction in Patients With Left Bundle Branch Block.J Am Heart Assoc. 2020 Jul 21;9(14):e015573. doi: 10.1161/JAHA.119.015573. Epub 2020 Jul 4. J Am Heart Assoc. 2020. PMID: 32627643 Free PMC article.
-
Influence of apelin-12 on troponin levels and the rate of MACE in STEMI patients.BMC Cardiovasc Disord. 2017 Jul 20;17(1):195. doi: 10.1186/s12872-017-0633-z. BMC Cardiovasc Disord. 2017. PMID: 28728608 Free PMC article.
-
Elevated Glucose on Admission Was an Independent Risk Factor for 30-Day Major Adverse Cardiovascular Events in Patients with STEMI but Not NSTEMI.Rev Cardiovasc Med. 2024 Jan 29;25(2):46. doi: 10.31083/j.rcm2502046. eCollection 2024 Feb. Rev Cardiovasc Med. 2024. PMID: 39077362 Free PMC article.
-
Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development.J Renin Angiotensin Aldosterone Syst. 2017 Oct-Dec;18(4):1470320317739987. doi: 10.1177/1470320317739987. J Renin Angiotensin Aldosterone Syst. 2017. PMID: 29141503 Free PMC article.
-
Predictors of Peak Troponin Level in Acute Coronary Syndromes: Prior Aspirin Use and SYNTAX Score.Int J Angiol. 2016 Mar;25(1):54-63. doi: 10.1055/s-0035-1547396. Epub 2015 Mar 23. Int J Angiol. 2016. PMID: 26900312 Free PMC article.
References
-
- Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007; 116(22): 2634–2653. - PubMed
-
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21(18): 1502–1513. - PubMed
-
- Goodman SG, Steg PG, Eagle KA, et al. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2006; 151(3): 654–660. - PubMed
-
- Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac‐specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335(18): 1342–1349. - PubMed
-
- Prasad A, Rihal CS, Lennon RJ, et al. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention. Circ Cardiovasc Intervent 2008; 1: 10–19. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical